Savara, Inc. (SVRA)
4.96
-0.20
(-3.88%)
USD |
NASDAQ |
Mar 20, 16:00
4.98
+0.02
(+0.40%)
After-Hours: 20:00
Savara Research and Development Expense (Quarterly) : 20.90M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 44.64M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Imunon, Inc. | 1.899M |